March 28, 2005
Celadrin® AlleviatesJoint Pain
Cetylated fattyacid topical cream (as Celadrin® by Imagenetix Inc.) helps patients with knee osteoarthritis(OA) to move more freely and with less pain, enabling them to engage in regularexercise, according to a study published in the February issue of the Journalof Strength and Conditioning Research (19, 1:115-121, 2005).
In the study, 40 patients with knee OA were randomized toreceive topical cetylated fatty acid twice daily or placebo, and were tested forimprovement in OA symptoms (including postural stability) at baseline andfollowing 30 days of treatment.
Based upon the results of the study, the researchers concluded30 days of treatment with a topical cetylated fatty acid cream improved posturalstability in patients with knee OA, presumably due to pain relief during quietstanding. They added such over-the-counter treatment may help improve theexercise trainability of people with OA.
The publication of this article is extremely significantbecause it shows that people with painful joint afflictions who use Celadrin cansuccessfully renew exercise programs without pain, said Bill Spencer,president of Imagenetix. Without exercise, these individuals are subject to ahost of health problems including obesity, to diabetes and heart disease.
You May Also Like
Sep 28, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023
The ashwagandha root production process: Where tradition meets science – article part threeSep 21, 2023
Former FDA employees weigh in on gov’t shutdownSep 27, 2023